Latest Articles
GLP-1 drugs found to lower cancer risk in diabetes patients - News-Medical.Net
GLP-1 drugs found to lower cancer risk in diabetes patients News-Medical.Net
Published: July 8, 2024, 7 a.m.
Medical student on track to be first MD/PhD graduate of Morsani College of Medicine - University of South Florida
Medical student on track to be first MD/PhD graduate of Morsani College of Medicine University of South Florida
Published: July 5, 2024, 7 a.m.
Gut Microbiota Disorder Contributes to the Production of IL-17A That E | JIR - Dove Medical Press
Gut Microbiota Disorder Contributes to the Production of IL-17A That E | JIR Dove Medical Press
Published: July 1, 2024, 7 a.m.
Rupture endometriomas presenting as acute abdomen infection | IMCRJ - Dove Medical Press
Rupture endometriomas presenting as acute abdomen infection | IMCRJ Dove Medical Press
Published: July 1, 2024, 7 a.m.
Offering cutting-edge care for endometriosis and fertility at Burjeel Medical City’s Advanced Gynecology Institute - Gulf News
Offering cutting-edge care for endometriosis and fertility at Burjeel Medical City’s Advanced Gynecology Institute Gulf News
Published: June 28, 2024, 7 a.m.
AI identifies new high-risk subtype in endometrial cancer - News-Medical.Net
AI identifies new high-risk subtype in endometrial cancer News-Medical.Net
Published: June 28, 2024, 7 a.m.
Study exposes algorithmic inequity in endometrial cancer detection for Black women - News-Medical.Net
Study exposes algorithmic inequity in endometrial cancer detection for Black women News-Medical.Net
Published: June 27, 2024, 7 a.m.
UBC researchers use AI to improve endometrial cancer diagnosis and treatment - News-Medical.Net
UBC researchers use AI to improve endometrial cancer diagnosis and treatment News-Medical.Net
Published: June 27, 2024, 7 a.m.
Scientists discover high-risk form of endometrial cancer—and how to test for it—using AI - Medical Xpress
Scientists discover high-risk form of endometrial cancer—and how to test for it—using AI Medical Xpress
Published: June 26, 2024, 7 a.m.
FDA approves Keytruda plus chemo for primary advanced, recurrent endometrial carcinoma - Medical Xpress
FDA approves Keytruda plus chemo for primary advanced, recurrent endometrial carcinoma Medical Xpress
Published: June 24, 2024, 7 a.m.
Link copied to clipboard!